Benitec Biopharma Ltd ADR (BNTC) support and resistance · $388.7M cap
Benitec Biopharma Ltd ADR (BNTC) is a biotechnology company listed on NASDAQ.
This page maps Benitec Biopharma Ltd ADR (BNTC) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported BNTC revenue for 2025-09-30 was $0. Net income was -$9.0M. BNTC currently screens at market cap $388.7M.
BNTC currently screens at market cap $388.7M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new BNTC 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the BNTC quote page for the session range and the stock page for the full model.
Not investment advice.